LFTQX Fees and Costs — MFS Lifetime 2070 Fund
Data updated: 2026-09-24
The net expense ratio is 0.80% (5.27% before fee waivers). This share class carries a maximum front-end sales load of 5.75% and a deferred sales charge of up to 1.00%.
LFTQX Fees and Expenses
Annual operating expenses and sales charges of LFTQX. Prospectus, as of April 30, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.00% |
| 12b-1 fee | 0.25% |
| Other expenses | 4.47% |
| Gross expense ratio | 5.27% |
| Fee waiver | −4.47% |
| Net expense ratio | 0.80% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 1.00% |
| Redemption fee | — |
LFTQX Costs Over Time
On $10,000 invested in LFTQX, assuming 5% a year before costs, total costs come to $1,207 over 5 years, cutting the return by 2.07% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $673 | $575 | $575 |
| Fund expenses (net expense ratio 0.80%) | $79 | $248 | $430 |
| Lost growth on money paid in costs | $29 | $103 | $202 |
| Total costs | $781 | $925 | $1,207 |
| Value after costs | $9,719 | $10,651 | $11,555 |
| Impact on return, per year | 7.81% | 2.88% | 2.07% |
MFS Lifetime 2070 Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| LFTZX | C000275571 | 0.41% | none |
| LFTWX | C000275572 | 0.55% | none |
| MLTQX | C000275576 | 0.55% | none |
| LFTQX | C000275574 | 0.80% | 5.75% |
| LFTVX | C000275573 | 0.80% | none |
| MLTTX | C000275578 | 1.05% | none |
| MLTPX | C000275577 | 1.55% | none |
| MLTRX | C000275575 | 1.55% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.